#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15658	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2136	727.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1469	1469	C	921	C	875	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15658	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2136	727.5	0	HET	.	.	.	C451T	.	451	451	C	736	736	C	917	C,T	668,200	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27930	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3649	762.1	0	.	n	.	0	T695C	SNP	695	695	T	1084	1084	C	918	C,T	870,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27930	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3649	762.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2360	2360	C	883	C,T	845,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27930	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3649	762.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2434	2434	A	903	A	851	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27930	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3649	762.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2986	2986	C	893	C,T,A	852,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2240	folP	855	855	100.0	folP.l15.c4.ctg.1	1651	135.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1013	1015	AGC	217;217;222	A;G;C	206;206;211	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6162	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3406	180.2	1	SNP	p	S91F	1	.	.	271	273	TTC	619	621	TTC	210;211;213	T;T;C	198;198;202	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6162	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3406	180.2	1	SNP	p	D95G	1	.	.	283	285	GGC	631	633	GGC	212;213;214	G,T;G;C	198,1;197;201	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6162	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3406	180.2	1	SNP	p	G95N	0	.	.	283	285	GGC	631	633	GGC	212;213;214	G,T;G;C	198,1;197;201	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1842	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1347	135.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	457	459	ACC	222;223;222	A;C;C	194;212;207	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1842	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1347	135.5	0	.	p	.	0	R44H	NONSYN	130	132	CGC	472	474	CAC	216;216;215	C;A;C	204;199;204	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1842	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1347	135.5	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	655	657	CAC	242;241;240	C;A;C	232;230;230	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1842	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1347	135.5	1	SNP	p	G45D	0	.	.	133	135	GGC	475	477	GGC	215;217;218	G;G;C	203;199;205	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	954	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1085	87.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2956	184.3	1	SNP	p	D86N	0	.	.	256	258	GAC	573	575	GAC	237;236;238	G;A;C	222;215;224	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2956	184.3	1	SNP	p	S87R	1	.	.	259	261	CGT	576	578	CGT	241;242;245	C;G;T	227;225;222	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2956	184.3	1	SNP	p	R87I	0	.	.	259	261	CGT	576	578	CGT	241;242;245	C;G;T	227;225;222	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2956	184.3	1	SNP	p	R87W	0	.	.	259	261	CGT	576	578	CGT	241;242;245	C;G;T	227;225;222	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2956	184.3	1	SNP	p	S88P	0	.	.	262	264	TCC	579	581	TCC	244;242;242	T;C;C	224;222;227	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4708	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2671	175.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1472	1474	GGC	218;214;214	G;G;C	206;202;201	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1203	1205	GCC	252;248;247	G;C;C	235;233;229	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1206	1208	ATG	249;253;253	A;T;G	235;240;239	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1218	1220	ACC	244;242;242	A;C;C	230;232;231	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1218	1220	ACC	244;242;242	A;C;C	230;232;231	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1719	1721	ACC	215;212;210	A;C;C	200;202;202	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1773	1775	GCG	206;210;217	G;C;G	197;203;210	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1773	1775	GCG	206;210;217	G;C;G	197;203;210	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1896	1898	GGT	173;169;170	G;G;T	164;160;159	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1905	1907	AGC	169;167;165	A;G;C	160;158;156	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4242	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2342	179.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1923	1925	CCG	153;160;164	C,G;CG,CGG;G	121,8;126,1;133	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5988	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3089	193.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1589	1591	CCG	223;225;228	C,A;C,T;G	201,1;209,1;206	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2460	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1697	143.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	538	538	C	146	C,T	140,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3030	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1813	166.0	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1151	1153	AGA	244;246;245	A;G;A	237;239;237	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3030	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1813	166.0	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1172	1174	GGT	235;235;235	G;G;T,G	227;228;225,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3030	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1813	166.0	1	SNP	p	G120K	1	.	.	358	360	AAG	881	883	AAG	240;243;247	A;A;G	218;225;223	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3030	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1813	166.0	1	SNP	p	N121D	0	.	.	361	363	AAC	884	886	AAC	244;240;243	A;A;C	220;215;221	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3030	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1813	166.0	1	SNP	p	A121N	1	.	.	361	363	AAC	884	886	AAC	244;240;243	A;A;C	220;215;221	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10842	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4923	219.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1260	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1099	114.1	1	SNP	p	V57M	1	.	.	169	171	ATG	525	527	ATG	244;245;247	A;T;G	232;233;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
